Search Results - "Sunar, Veli"

Clinicopathological features of non-carcinoid malignant epithelial appendix tumors and risk factors for recurrence, single-center experience by Ates, Ozturk, Aksel, Bulent, Karadag, Ibrahim, Karakaya, Serdar, Sunar, Veli, Oksuzoglu, O. Berna

“…Background: Non-carcinoid appendix epithelial tumors are rare. These tumors include low-grade and high-grade mucinous neoplasm also adenocarcinomas. We aimed…”
Get full text

Serum endocan level and its prognostic significance in breast cancer patients by Ates, Ozturk, Gedik, Emre, Sunar, Veli, Altundag, Kadri

“…Endocan, known as endothelial cell specific molecule (ESM), is a novel endothelial dysfunction marker. The aim of this study is to examine the plasma endocan…”
Get full text

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer by Sunar, Veli, Korkmaz, Vakkas, Topcu, Vehap, Cavdarli, Büşranur, Arik, Zafer, Ozdal, Bülent, Ustun, Yaprak Engin

“…Aim This study aims to determine the frequency of germline BRCA 1/2 mutations in Turkish women with epithelial ovarian cancer (EOC) and evaluate its…”
Get full text

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study by Bilici, Ahmet, Koca, Sinan, Karaagac, Mustafa, Aydin, Sabin Goktas, Eraslan, Emrah, Kaplan, Muhammed Ali, Ocak, Birol, Goksu, Sema Sezgin, Paydas, Semra, Akgul, Fahri, Derin, Sumeyye, Ergun, Yakup, Yekeduz, Emre, Erol, Cihan, Ozyukseler, Deniz Tataroglu, Demiray, Atike Gokcen, Karaca, Mustafa, Guc, Zeynep Gulsum, Menekse, Serkan, Cinkir, Havva Yesil, Gumusay, Ozge, Sakin, Abdullah, Ozkul, Ozlem, Demir, Hacer, Erdem, Dilek, Besiroglu, Mehmet, Unal, Olcun Umit, Acar, Ramazan, Koral, Lokman, Sahin, Suleyman, Sakalar, Teoman, Bahceci, Aykut, Ozveren, Ahmet, Gunaydin, Ulug Mutlu, Seker, Mehmet Metin, Sunar, Veli, Dal, Pinar, Artac, Mehmet, Turhal, Serdar

“…Aim Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS)…”
Get full text

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study by Taşçı, Elif Şenocak, Kutlu, Yasin, Ölmez, Ömer Fatih, Mutlu, Arda Ulaş, Gündoğdu, Yasemin, Seyyar, Mustafa, Şahin, Elif, Çabuk, Devrim, Majidova, Nargiz, Uğurlu, İrem, Demirci, Ayşe, Aydın, Dinçer, Çavdar, Eyyüp, Bayram, Selami, Yıldırım, Nilgün, Karataş, Fatih, Eryılmaz, Melek Karakurt, Çağlayan, Dilek, Menekşe, Serkan, Kut, Engin, Arak, Hacı, Keser, Murat, Sunar, Veli, Perkin, Perihan, Şakalar, Teoman, Oyan, Başak, Sönmez, Özlem, Özer, Leyla, Yıldız, İbrahim

“…Triple negative breast cancer (TNBC) is characterized by high rates of recurrence, especially in patients with residual disease after neoadjuvant chemotherapy…”
Get more information

Association between androgen receptor status and prognosis in triple negative breast cancer by Sunar, Veli, T Dogan, Hayriye, Sarici, Furkan, Ates, Ozturk, Akin, Serkan, Baspinar, Batuhan, Aksoy, Sercan, Altundag, Kadri

“…Triple negative breast cancer (TNBC) is a heterogeneous disease group with a higher recurrence risk and poorer prognosis. In this study, we aimed to…”
Get more information

Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8‐day regimen for treatment of low‐risk gestational trophoblastic neoplasia by Korkmaz, Vakkas, Sunar, Veli, Akar, Serra, Alinca, Cihat Murat, Arik, Zafer, Boran, Nurettin, Ozdal, Bülent, Ustun, Yaprak Engin

“…Aim We aimed to compare weekly methotrexate (MTX) regimen and methotrexate‐folinic acid (MTX‐FA) 8‐day regimen in the first line treatment of low‐risk…”
Get full text

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer by Kahraman, Seda, Erul, Enes, Seyyar, Mustafa, Gumusay, Ozge, Bayram, Ertugrul, Demirel, Burcin Cakan, Acar, Omer, Aksoy, Sercan, Baytemur, Naziyet Kose, Sahin, Elif, Cabuk, Devrim, Basaran, Gul, Paydas, Semra, Yaren, Arzu, Guven, Deniz Can, Erdogan, Atike Pinar, Demirci, Umut, Yasar, Alper, Bayoglu, İbrahim Vedat, Hizal, Mutlu, Gulbagci, Burcu, Paksoy, Nail, Davarci, Sena Ece, Yilmaz, Funda, Dogan, Ozlem, Orhan, Sibel Oyucu, Kayikcioglu, Erkan, Aytac, Ali, Keskinkilic, Merve, Mocan, Eda Eylemer, Unal, Olcun Umit, Aydin, Esra, Yucel, Hakan, Isik, Deniz, Eren, Onder, Uluc, Basak Oyan, Ozcelik, Melike, Hacibekiroglu, Ilhan, Aydiner, Adnan, Demir, Hacer, Oksuzoglu, Berna, Cilbir, Ebru, Cubukcu, Erdem, Cetin, Bulent, Oktay, Esin, Erol, Cihan, Okutur, Sadi Kerem, Yildirim, Nilgun, Alkan, Ali, Selcukbiricik, Fatih, Aksoy, Asude, Karakas, Yusuf, Ozkanli, Gulhan, Duman, Berna Bozkurt, Aydin, Dincer, Dulgar, Ozgecan, Er, Muhammed Muhiddin, Teker, Fatih, Yavuzsen, Tugba, Aykan, Musa Baris, Inal, Ali, Iriagac, Yakup, Kalkan, Nurhan Onal, Keser, Murat, Sakalar, Teoman, Menekse, Serkan, Kut, Engin, Bilgin, Burak, Karaoglanoglu, Muge, Sunar, Veli, Ozdemir, Ozlem, Turhal, Nazim Serdar, Karadurmus, Nuri, Yalcin, Bulent, Sendur, Mehmet Ali Nahit

“…Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for…”
Get full text

The retrospective analysis of central nervous system lymphomas: Single-center experience by Sunar, Veli, Yasar, Arzu, Sarici, Furkan, Esin, Ece, Diker, Omer, Lacin, Sahin, Turker, Alev, Ozdemir, Evren, Barista, Ibrahim, Kars, Ayse

“…Abstract only…”
Get full text

Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience by Karakas, Yusuf, Lacin, Sahin, Kurtulan, Olcay, Esin, Ece, Sunar, Veli, Sokmensuer, Cenk, Kilickap, Saadettin, Yalcin, Suayib

“…Background/Aims: Gastric neuroendocrine tumors (G-NETs) are rare tumors, but their incidence is gradually increasing. Despite the existence of many…”
Get full text

Retrospective Analysis of Gestational Trophoblastic Neoplasia: Single Center Experience by SUNAR, VELI

Get full text

The short-term safety of adjuvant paclitaxel plus trastuzumab - A single centre experience by Ates, Ozturk, Sunar, Veli, Aslan, Alma, Karatas, Fatih, Sahin, Suleyman, Altundag, Kadri

“…HER2-amplified breast cancer (BC) has a poor prognosis. The combination of trastuzumab with chemotherapy in the adjuvant setting decreases recurrence and…”
Get more information

Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real Life Experience by yılmaz, mukaddes

Get full text

Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience by Diker, Omer, Babacan, Taner, Buyukhatipoglu, Hakan, Kertmen, Neyran, Balakan, Ozan, Sever, Ali Rıza, Unlu, Ozan, Ates, Ozturk, Sarici, Saim Furkan, Akin, Serkan, Sunar, Veli, Karakas, Yusuf, Lacin, Sahin, Altundag, Kadri

“…Abstract only…”
Get full text

The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival by Sunar, Veli, Ates, Ozturk, Aslan, Alma Korcali, Karakas, Yusuf, Altundag, Mustafa Kadri

“…Objectives: This study aims to investigate the prevalence of systemic rheumatic diseases (SRDs) among patients with breast cancer (BC) and to identify the…”
Get full text

When should we give aromatase inhibitors for insomnia; early in the day or after dinner? by Ates, Ozturk, Sunar, Veli, Sever, Ali R, Altundag, Kadri

Get more information

Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab by Ates, Ozturk, Sunar, Veli, Babacan, Taner, Akin, Serkan, Kertmen, Neyran, Altundag, Kadri

Get more information

Prognostic Factors In Breast Cancer Patients With Hepatic Metastases: Impact Of Molecular Subtype And Local Hepatic Treatment by ATES, OZTURK

Get full text

Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience by Sarici, Furkan, Babacan, Taner, Buyukhatipoglu, Hakan, Balakan, Ozan, Sever, Ali R, Kertmen, Neyran, Unlu, Ozan, Ates, Ozturk, Diker, Omer, Akin, Serkan, Sunar, Veli, Karakas, Yusuf, Lacin, Sahin, Altundag, Kadri

“…Educational status may be an important parameter in assessing breast cancer risk and prognosis. The purpose of this study was to investigate the correlation…”
Get more information